about
Spatiotemporal control over growth factor signaling for therapeutic neovascularizationEndothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress?Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activationSmads as therapeutic targets for chronic kidney diseasePEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseasesRemote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulcerationAntimycotic ciclopirox olamine in the diabetic environment promotes angiogenesis and enhances wound healingGlucose toxic effects on granulation tissue productive cells: the diabetics' impaired healing.Diabetes-associated macrovascular complications: cell-based therapy a new tool?Dysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitusEndothelial alpha1-adrenoceptors regulate neo-angiogenesisTumour vascularization: sprouting angiogenesis and beyondCoadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats.Cancer biology in diabetes.A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes.Elevated fibroblast growth factor-2 increases tumor necrosis factor-alpha induced endothelial cell death in high glucoseThioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic ratsAttenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic ratsRole of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferationHigh-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism.Aging and diabetes impair the neovascular potential of adipose-derived stromal cells.Glycaemic variability affects ischaemia-induced angiogenesis in diabetic mice.Gr-1+CD11b+ myeloid cells efficiently home to site of injury after intravenous administration and enhance diabetic wound healing by neoangiogenesis.Spectral imaging reveals microvessel physiology and function from anastomoses to thromboses.Human CD34+ stem cells promote healing of diabetic foot ulcers in rats.Improved function of diabetic wound-site macrophages and accelerated wound closure in response to oral supplementation of a fermented papaya preparation.Modulating Notch signaling to enhance neovascularization and reperfusion in diabetic mice.Techniques and assays for the study of angiogenesis.Angiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model.Sprouty2 downregulates angiogenesis during mouse skin wound healing.Effects of pulsed infra-red low level-laser irradiation on mast cells number and degranulation in open skin wound healing of healthy and streptozotocin-induced diabetic rats.Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes.Inhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study.Hypo- and hyperglycemia impair endothelial cell actin alignment and nitric oxide synthase activation in response to shear stress.Transdermal deferoxamine prevents pressure-induced diabetic ulcers.Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.Angiogenesis in diabetes and obesityWound bed preparation for ischemic diabetic foot ulcer.
P2860
Q24641819-99A3DCD4-7523-4E3F-BD88-74F34127C7EEQ26851362-8E2B1621-2C18-4A7D-84D7-06405DDEC809Q26864770-CFF085F1-7150-4079-A559-5742ACC60770Q26865998-934EFACB-C19D-4F87-BDBE-491E018EBD75Q27026916-B744256A-A966-4894-A5F4-375786273577Q28078462-BFD00ED1-5F40-4E38-8547-96ECE2A23207Q28478087-5186276C-9C74-4C00-AD2A-BE05A660520BQ30428132-9400310A-969C-40E5-BA56-892AB8FCD084Q30428895-D75FF7CD-CFE3-4399-A947-8DED7D9E25C6Q30461411-4AE38E6F-A50F-467A-B765-C3112FAFB756Q33310598-F27A9137-6BEE-4B92-8344-8E17C39C8197Q33556162-84663092-ECF4-4088-9217-320C4DF6A07AQ33556657-B04A15FE-D9A2-4664-8188-2B163F6438C0Q33608038-A8990FD3-2174-4EFF-8B45-3CEF1FB71D1CQ33648934-28DF0944-6226-4024-A3A9-984FABBEA102Q33726224-38827A3B-CE8E-47AF-91A5-7D3C80997CABQ33782221-31CD2013-68D3-412E-84D2-CC8B8286C7B4Q33793466-6B1BF41B-7E9A-4154-86A4-78F41EBF59F7Q33817206-7508182B-7F27-4464-87BD-7E8FC254AD8DQ33869816-DD6F961E-8343-438A-B1CC-2CA386DAD641Q33886099-CF7BD822-B81F-4B6D-B010-028A75698202Q33950813-23E479BA-0F06-4477-8CAD-8F080A60D4AAQ33954420-BAB9F02D-FB78-411A-AA70-A932C6367B2AQ34049847-A3695058-5DC6-4082-90A0-55366DAF7EB9Q34096748-D7D1F60D-ACAA-4466-A791-18D9A5BC404EQ34110100-5A6587EE-FF67-4E43-8FF3-6DC7DD80A396Q34172388-7AAE818A-6FB0-4462-95C5-20196F879717Q34438399-A1C430B9-ED00-440E-9EB6-362B5B7A0D51Q34441960-8056F67A-D497-49BC-902B-237A6875212BQ34596705-64C675A3-A5BD-4963-82F8-39862DB699EAQ34600328-B786B765-5A39-479C-9BDD-50A4DDF0FDE5Q34609684-0AD173FA-71DC-49C3-8D01-7DBAD250986CQ34620720-C55DCA9C-F780-4660-BDFF-505C304FCCFCQ34679918-353997A5-FC0E-4A20-A6F8-79B4B11EA814Q34686210-A256C23F-B7D6-47F9-A594-FF99DB857723Q34776387-687DB30F-B7BC-4A94-B6D0-FF6E8C2F919EQ34926164-CA5761B3-8120-42B1-9073-CD4DE56E0381Q35098397-6A7E180C-8414-483C-8081-B277F1B47B7AQ35153884-20794D3F-518D-45B7-B159-3D45FD184E6BQ35173647-8CA7715D-A5DB-4A36-BCDA-499B1C6D59CF
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Abnormal angiogenesis in diabetes mellitus.
@ast
Abnormal angiogenesis in diabetes mellitus.
@en
type
label
Abnormal angiogenesis in diabetes mellitus.
@ast
Abnormal angiogenesis in diabetes mellitus.
@en
prefLabel
Abnormal angiogenesis in diabetes mellitus.
@ast
Abnormal angiogenesis in diabetes mellitus.
@en
P2860
P356
P1476
Abnormal angiogenesis in diabetes mellitus.
@en
P2093
David C Sane
Michael R Komada
P2860
P304
P356
10.1002/MED.10024
P577
2003-03-01T00:00:00Z